Otsuka (OTCMKTS:OTSKF – Get Free Report) will likely be releasing its resultson Friday, July 31st. Analysts expect Otsuka to post earnings of $0.9660 per share and revenue of $3.9373 billion for the quarter.
Otsuka Stock Performance
OTSKF opened at $66.50 on Friday. The company’s 50-day simple moving average is $65.13 and its two-hundred day simple moving average is $64.94. Otsuka has a 52-week low of $54.26 and a 52-week high of $72.22.
Otsuka Company Profile
Otsuka Holdings Co, Ltd., trading on OTC markets as OTSKF, is a global healthcare company headquartered in Tokyo, Japan. Established in 1964 as a research-driven pharmaceutical firm, Otsuka has since evolved into a diversified holding company overseeing operations in pharmaceuticals, nutraceuticals and consumer products. The company operates through a network of subsidiaries, including Otsuka Pharmaceutical Co, Ltd., Otsuka America Pharmaceutical, Inc, and Otsuka Europe, each focusing on drug development, manufacturing and distribution.
In its pharmaceutical division, Otsuka is best known for discovering and commercializing treatments in areas such as psychiatry, oncology and nephrology.
Further Reading
- Five stocks we like better than Otsuka
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.
